{"id":"https://openalex.org/W1982650591","doi":"https://doi.org/10.1002/ajh.23568","title":"Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non\u2010Hodgkin's lymphoma","display_name":"Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non\u2010Hodgkin's lymphoma","publication_year":2013,"publication_date":"2013-08-20","ids":{"openalex":"https://openalex.org/W1982650591","doi":"https://doi.org/10.1002/ajh.23568","mag":"1982650591","pmid":"https://pubmed.ncbi.nlm.nih.gov/23959599","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4150545"},"language":"en","primary_location":{"id":"doi:10.1002/ajh.23568","doi":"https://doi.org/10.1002/ajh.23568","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajh.23568","pdf_url":null,"source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4150545","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102896676","display_name":"Jeffrey Alan Jones","orcid":"https://orcid.org/0000-0001-9557-0820","observed_orcids":["https://orcid.org/0000-0001-9557-0820"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey A. Jones","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070597835","display_name":"Amy S. Rupert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy S. Rupert","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075462619","display_name":"Ming Jye Poi","orcid":"https://orcid.org/0000-0001-6065-8662","observed_orcids":["https://orcid.org/0000-0001-6065-8662"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ming Poi","raw_affiliation_strings":["Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066257150","display_name":"Mitch A. Phelps","orcid":"https://orcid.org/0000-0002-1615-5280","observed_orcids":["https://orcid.org/0000-0002-1615-5280"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitch A. Phelps","raw_affiliation_strings":["Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039283256","display_name":"Leslie Ann Andritsos","orcid":"https://orcid.org/0000-0003-0222-1766","observed_orcids":["https://orcid.org/0000-0003-0222-1766"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Andritsos","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012846289","display_name":"Robert A. Baiocchi","orcid":"https://orcid.org/0000-0002-1619-4853","observed_orcids":["https://orcid.org/0000-0002-1619-4853","https://orcid.org/0000-0002-6518-8169"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Baiocchi","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112786802","display_name":"Don M. Benson","orcid":"https://orcid.org/0000-0001-8837-0548","observed_orcids":["https://orcid.org/0000-0001-8837-0548"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don M. Benson","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056946123","display_name":"Kristie A. Blum","orcid":"https://orcid.org/0000-0001-7363-9794","observed_orcids":["https://orcid.org/0000-0001-7363-9794","https://orcid.org/0000-0003-4229-2569"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristie A. Blum","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104068814","display_name":"Beth A. Christian","orcid":"https://orcid.org/0009-0008-6077-3669","observed_orcids":["https://orcid.org/0009-0008-6077-3669"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Christian","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019749214","display_name":"Joseph M. Flynn","orcid":"https://orcid.org/0000-0003-1767-9235","observed_orcids":["https://orcid.org/0000-0003-1767-9235"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Flynn","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044663373","display_name":"Sam L. Penza","orcid":"https://orcid.org/0000-0002-4217-5496","observed_orcids":["https://orcid.org/0000-0002-4217-5496"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sam Penza","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041950455","display_name":"Pierluigi Porcu","orcid":"https://orcid.org/0000-0002-8056-023X","observed_orcids":["https://orcid.org/0000-0002-8056-023X"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pierluigi Porcu","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051619378","display_name":"Michael R. Grever","orcid":"https://orcid.org/0000-0002-1605-7875","observed_orcids":["https://orcid.org/0000-0002-1605-7875"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Grever","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["Division of Hematology, The Ohio State University, Columbus, Ohio","Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102896676"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":4.4095,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.95004476,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"89","issue":"1","first_page":"19","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":1.0},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7450000047683716},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.7680000066757202},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7820000052452087},{"id":"https://openalex.org/keywords/indolent-b-cell-lymphoma","display_name":"indolent B-cell lymphoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":1.0},{"id":"https://openalex.org/keywords/transformed-lymphoma","display_name":"transformed lymphoma","score":0.7009999752044678},{"id":"https://openalex.org/keywords/tumor-lysis-syndrome","display_name":"tumor lysis syndrome","score":0.8100000023841858},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8469094038009644},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6369976997375488},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.585507869720459},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.5530713200569153},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5470888614654541},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5057260990142822},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4837058186531067},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47095996141433716},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4489162564277649},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.42977243661880493},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4163004159927368},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34535685181617737},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33806881308555603}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/ajh.23568","doi":"https://doi.org/10.1002/ajh.23568","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajh.23568","pdf_url":null,"source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:23959599","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23959599","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hematology","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pubmedcentral.nih.gov:4150545","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4150545","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Hematol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4150545","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4150545","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Hematol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2513009810","display_name":null,"funder_award_id":"N01 CM062207","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G258994785","display_name":"Phase I Trials of Anti-Cancer Agents","funder_award_id":"U01CA076576","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3007936770","display_name":null,"funder_award_id":"P01 CA81534","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G383557375","display_name":null,"funder_award_id":"N01CM62207","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4003936468","display_name":"The Ohio State University Center for clinical and Translational Science","funder_award_id":"UL1TR001070","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8144716091","display_name":"Early Therapeutics Development with Phase II Emphasis","funder_award_id":"n01cm62207-12-0-1","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8225889400","display_name":"Chronic Lymphocytic Leukemia Research Consortium","funder_award_id":"4p01ca081534-16","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000907317","display_name":"The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network","funder_award_id":"UM1CA186712","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G944802235","display_name":null,"funder_award_id":"P01-CA-081534","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1831621090","https://openalex.org/W1912693401","https://openalex.org/W1989819905","https://openalex.org/W2017898416","https://openalex.org/W2021695924","https://openalex.org/W2024571011","https://openalex.org/W2060287372","https://openalex.org/W2072694036","https://openalex.org/W2072874976","https://openalex.org/W2078619764","https://openalex.org/W2086713592","https://openalex.org/W2091891984","https://openalex.org/W2105172500","https://openalex.org/W2106392930","https://openalex.org/W2134654194","https://openalex.org/W2139582914","https://openalex.org/W2139793858","https://openalex.org/W2150439521","https://openalex.org/W2168929418"],"related_works":["https://openalex.org/W2591336637","https://openalex.org/W2527377099","https://openalex.org/W2017898416","https://openalex.org/W2258866093","https://openalex.org/W2583721613","https://openalex.org/W1989819905","https://openalex.org/W2550700223","https://openalex.org/W2072874976","https://openalex.org/W2559438965","https://openalex.org/W2588092501"],"abstract_inverted_index":{"Flavopiridol":[0],"is":[1],"a":[2,23,40,175],"broad":[3],"cyclin-dependent":[4],"kinase":[5],"inhibitor":[6],"(CDKI)":[7],"that":[8,214],"induces":[9],"apoptosis":[10],"of":[11,60,100,174,184,209],"malignant":[12],"lymphocytes":[13],"in":[14,17,58,97,119,135,153,182,217,223,229],"vitro":[15],"and":[16,50,78,112,123,139,147,201,228],"murine":[18],"lymphoma":[19,75],"models.":[20],"We":[21],"conducted":[22],"Phase":[24],"I":[25],"dose-escalation":[26],"study":[27,222],"to":[28,46],"determine":[29],"the":[30,98,148,157],"maximum":[31],"tolerated":[32],"dose":[33,159],"(MTD)":[34],"for":[35,128,170,188],"single-agent":[36,207],"flavopiridol":[37],"administered":[38],"on":[39],"pharmacokinetically":[41],"derived":[42],"hybrid":[43],"dosing":[44],"schedule":[45],"patients":[47,87,101,125,186],"with":[48,192],"relapsed":[49],"refractory":[51],"non-Hodgkin's":[52],"lymphoma.":[53],"Dose":[54,131],"was":[55,95,105,117,133,150,180],"escalated":[56],"independently":[57],"one":[59,202],"four":[61],"cohorts:":[62],"indolent":[63,199],"B-cell":[64,72],"(Cohort":[65,69,76,84],"1),":[66],"mantle":[67,196],"cell":[68],"2),":[70],"intermediate-grade":[71],"including":[73,190],"transformed":[74],"3),":[77],"T-/NK-cell":[79],"excluding":[80],"primary":[81],"cutaneous":[82],"disease":[83],"4).":[85],"Forty-six":[86],"were":[88,144],"accrued.":[89],"Grade":[90],"3":[91],"or":[92],"4":[93,171],"leukopenia":[94],"observed":[96,118,181],"majority":[99],"(60%),":[102],"but":[103],"infection":[104],"infrequent.":[106],"Common":[107],"nonhematologic":[108],"toxicities":[109,143],"included":[110],"diarrhea":[111],"fatigue.":[113],"Biochemical":[114],"tumor":[115],"lysis":[116],"only":[120],"two":[121,136],"patients,":[122],"no":[124],"required":[126],"hemodialysis":[127],"its":[129],"management.":[130],"escalation":[132],"completed":[134],"cohorts":[137],"(indolent":[138],"aggressive":[140],"B-cell).":[141,205],"Dose-limiting":[142],"not":[145,151],"observed,":[146],"MTD":[149],"reached":[152],"either":[154],"cohort":[155],"at":[156],"highest":[158],"tested":[160],"(50":[161],"mg/m(2)":[162,166],"bolus":[163],"+":[164],"50":[165],"continuous":[167],"infusion":[168],"weekly":[169],"consecutive":[172],"weeks":[173],"6-week":[176],"cycle).":[177],"Clinical":[178],"benefit":[179],"26%":[183],"43":[185],"evaluable":[187],"response,":[189],"14%":[191],"partial":[193],"responses":[194],"(two":[195],"cells,":[197],"three":[198],"B-cells,":[200],"diffuse":[203],"large":[204],"The":[206],"activity":[208],"this":[210,218],"first-generation":[211],"CDKI":[212],"suggests":[213],"other":[215],"agents":[216],"class":[219],"merit":[220],"further":[221],"lymphoid":[224],"malignancies,":[225],"both":[226],"alone":[227],"combination.":[230]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}